510(k) K960531
K960531 is an FDA 510(k) premarket notification submitted by Dako Corp. for the device "MOUSE ANTI-HUMAN CD3, T-CELL/FITC & CD19, B-CELL/RPE". The FDA issued a decision of Substantially Equivalent on June 14, 1996. The device falls under product code GKZ (Counter, Differential Cell), a Class II device regulated under 21 CFR 864.5220. Dako Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 14, 1996
- Date Received
- February 7, 1996
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Counter, Differential Cell
- Device Class
- Class II
- Regulation Number
- 864.5220
- Review Panel
- HE
- Submission Type